<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="preprint">
<?all-math-mml yes?>
<?use-mml?>
<?origin ukpmcpa?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">bioRxiv</journal-id>
<journal-title-group>
<journal-title>bioRxiv : the preprint server for biology</journal-title>
</journal-title-group>
<issn pub-type="ppub"/>
</journal-meta>
<article-meta>
<article-id pub-id-type="manuscript">EMS94986</article-id>
<article-id pub-id-type="doi">10.1101/2020.09.09.290718</article-id>
<article-id pub-id-type="archive">PPR213361</article-id>
<article-version article-version-type="publisher-id">1</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Daytime variation in SARS-CoV-2 infection and cytokine production</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Bailo Diallo</surname>
<given-names>Aïssatou</given-names>
</name>
<degrees>MSc</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gay</surname>
<given-names>Laetitia</given-names>
</name>
<degrees>MSc</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Coiffard</surname>
<given-names>Benjamin</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Leone</surname>
<given-names>Marc</given-names>
</name>
<degrees>MD</degrees>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Mezouar</surname>
<given-names>Soraya</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Mege</surname>
<given-names>Jean-Louis</given-names>
</name>
<degrees>MD</degrees>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Aix-Marseille UniV, MEPHI, IRD, APHM, Marseille, France</aff>
<aff id="A2">
<label>2</label>IHU-Méditerranée Infection, Marseille, France</aff>
<aff id="A3">
<label>3</label>Aix Marseille Université, Assistance Publique Hôpitaux de Marseille, Hôpital Nord, Service d’Anesthésie et de Réanimation, Marseille, France</aff>
<aff id="A4">
<label>4</label>APHM, UF Immunologie, Marseille, France</aff>
<author-notes>
<corresp id="CR1">
<label>*</label>Corresponding authors : Professor Jean-Louis MEGE and Doctor Soraya MEZOUAR, IHU Méditerranée Infection, 19-21, Boulevard Jean Moulin, 13385 Marseille, France, Phone: (+33) 4 13 73 20 51, Fax: (+33) 4 13 73 20 52, <email>jean-louis.mege@univ-amu.fr</email> and <email>soraya.mezouar@univ-amu.fr</email>
</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>13</day>
<month>09</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="preprint">
<day>12</day>
<month>09</month>
<year>2020</year>
</pub-date>
<permissions>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nd/4.0/">
<license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nd/4.0/">CC BY-ND 4.0 International license</ext-link>.</license-p>
</license>
</permissions>
<abstract>
<p id="P1">S. Ray and A. Reddy recently anticipated the implication of circadian rhythm in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causative agent of the coronavirus disease (Covid-19). In addition to its key role in the regulation of biological functions, the circadian rhythm has been suggested as a regulator of viral infections. Specifically, the time of day of infection was found critical for illness progression, as has been reported for influenza, respiratory syncytial and parainfluenza type 3 viruses. We analyzed circadian rhythm implication in SARS-CoV-2 virus infection of isolated human monocytes, key actor cells in Covid-19 disease, from healthy subjects. The circadian gene expression of <italic>Bmall</italic> and <italic>Clock</italic> genes was investigated with q-RTPCR. Monocytes were infected with SARS-CoV-2 virus strain and viral infection was investigated by One-Step qRT-PCR and immunofluorescence. Interleukin (IL)-6, IL-Ιβ and IL-10 levels were also measured in supernatants of infected monocytes. Using Cosinor analysis, we showed that <italic>Bmall</italic> and <italic>Clock</italic> transcripts exhibited circadian rhythm in monocytes with an acrophase and a bathyphase at Zeitgeber Time (ZT)6 and ZT17. After forty-eight hours, the amount of SARS-CoV-2 virus increased in the monocyte infected at ZT6 compared to ZT17. The high virus amount at ZT6 was associated with significant increased release in IL-6, IL.-1β and IL-10 compared to ZT17. Our results suggest that time day of SARS-CoV-2 infection affects viral infection and host immune response. They support consideration of circadian rhythm in SARS-CoV-2 disease progression and we propose circadian rhythm as a novel target for managing viral progression.</p>
<sec id="S1">
<title>Importance</title>
<p id="P2">The implication of circadian rhythm (CR) in pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has been recently anticipated. The time of day of infection is critical for illness progression as reported for influenza, respiratory syncytial and parainfluenza type 3 viruses. In this study, we wondered if SARS-CoV-2 infection and cytokine production by human monocytes, innate immune cells affected by Covid-19, were regulated by CR. Our results suggest that time day of SARS-CoV-2 infection affects viral infection and host immune response. They support consideration of circadian rhythm in SARS-CoV-2 disease progression and we propose circadian rhythm as a novel target for managing viral progression.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Covid-19</kwd>
<kwd>circadian rhythm</kwd>
<kwd>monocytes</kwd>
<kwd>inflammatory cytokine</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="S2" sec-type="intro">
<title>Introductory</title>
<p id="P3">The implication of circadian rhythm (CR) in pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has been recently anticipated (<xref ref-type="bibr" rid="R1">1</xref>, <xref ref-type="bibr" rid="R2">2</xref>). The CR regulates physiological processes in living organisms with a period of 24 hours (<xref ref-type="bibr" rid="R3">3</xref>). Rhythmicity depends on central and peripheral oscillators whose activity relies on two main feedback loops managed by a clock genes cascade under the regulation of the main clock gene <italic>Bmall</italic> (<xref ref-type="bibr" rid="R3">3</xref>). The host susceptibility to microorganism is likely under control of biological clocks (<xref ref-type="bibr" rid="R4">4</xref>). The time of day of infection is critical for illness progression as reported for influenza, respiratory syncytial and parainfluenza type 3 viruses (<xref ref-type="bibr" rid="R5">5</xref>-<xref ref-type="bibr" rid="R7">7</xref>). We previously reported that CR is a key actor at the interface between infection susceptibility, clinical presentation and prognosis of infection (<xref ref-type="bibr" rid="R4">4</xref>, <xref ref-type="bibr" rid="R8">8</xref>).</p>
<p id="P4">There are some evidences that enable to anticipate the role of CR in SARS-CoV-2 infection. The absence of <italic>Bmall</italic> has an impact on intracellular replication of coronaviruses, especially vesicular trafficking, endoplasmic reticulum and protein biosynthesis (<xref ref-type="bibr" rid="R9">9</xref>). Knock-out of <italic>Bmall</italic> markedly decreases the replication of several viruses such as Dengue or Zika (<xref ref-type="bibr" rid="R10">10</xref>). Finally, among key proteins involved in SARS-CoV-2 interaction with the host recently published (<xref ref-type="bibr" rid="R11">11</xref>), it has been identified 30% of them being associated with circadian pathway (<xref ref-type="bibr" rid="R1">1</xref>). Clearly, the evidences of an implication of CR in SARS-CoV-2 infection of human cells are lacking. In this study, we wondered if SARS-CoV-2 infection and cytokine production by human monocytes, innate immune cells affected by Covid-19, were regulated by CR.</p>
</sec>
<sec id="S3" sec-type="results | discussion">
<title>Results and Discussion</title>
<p id="P5">We first wondered if the infection of monocytes, innate immune cells affected by Covid-19 (<xref ref-type="bibr" rid="R12">12</xref>), obey to circadian oscillations. Every 3 hours during 24 hours, total RNA was extracted and expression of <italic>Bmall</italic> and <italic>Clock</italic> genes was investigated in unstimulated monocytes as previously described (<xref ref-type="bibr" rid="R8">8</xref>). Expression of investigating genes exhibited CR in monocytes with an acrophase (peak of the rhythm) and a bathyphase (trough of the rhythm) at Zeitgeber (German name for synchronizer) Time (ZT)6 and ZT17 (<xref ref-type="fig" rid="F1">Fig.1A</xref>). These two time points represent the beginning of the active and the resting periods in humans (<xref ref-type="bibr" rid="R13">13</xref>). To assess the involvement of CR in infection of monocytes with SARS-CoV-2, we incubated monocytes with SARS-CoV-2 during the bathyphase (ZT6) and acrophase (ZT17) during 48 hours. Then, viral RNA was extracted to evaluate Covid-19 virus amount and the phagocytosis index was calculated at ZT6 and ZT17 using immunofluorescence. The amount of SARS-CoV-2 virus was higher in monocytes cultured at ZT6 than at ZT17, suggesting a daytime dependent of viral multiplication (<xref ref-type="fig" rid="F1">Fig.1B</xref>). This result was strengthened by high phagocytosis index at ZT6 compared to ZT17 (<xref ref-type="fig" rid="F1">Fig.1C</xref>). Our data showed for the first time that entry and multiplication of SARS-CoV-2 in human monocytes varies with the time of day. This finding is reminiscent of what has been previously reported with herpes and influenza virus in murine models of infection (<xref ref-type="bibr" rid="R6">6</xref>, <xref ref-type="bibr" rid="R7">7</xref>). It is noteworthy that CRs are different in rodents and humans, thus limitating extrapolations to understand pathogenesis of SARS-CoV-2 infection.</p>
<p id="P6">Covid-19 disease is characterized by runaway immune system leading to a cytokine storm consisting of high circulating levels of cytokines including IL-6, IL.-1β and IL-10 (<xref ref-type="bibr" rid="R14">14</xref>). We wondered if the interaction of SARS-CoV-2 with monocytes affected cytokine production at two points of the CR. The amounts of IL-1β, IL-6 and IL-10 were significantly increased at ZT6 (<xref ref-type="fig" rid="F1">Fig.1D</xref>) when the amount of infection is highest. Hence, the interaction of SARS-CoV-2 with monocytes resulted in distinct cytokine pattern according to daytime.</p>
<p id="P7">We demonstrate here that the time day of SARS-CoV-2 infection determines consistently viral infection/replication and host immune response. It is likely that SARS-CoV-2 exploits clock pathway for its own gain. Our findings support consideration of CR in SARS-CoV-2 disease progression and suggest that CR represents a novel target for managing viral progression. This study also highlights the importance of the time of treatment administration to Covid-19 patients since CR was found regulating pharmacokinetics of several drugs (<xref ref-type="bibr" rid="R15">15</xref>). Several treatments are proposed to prevent the occurrence of severe forms in Covid-19. They include passive immunization, cytokines, anti-cytokine antibody or corticoids (<xref ref-type="bibr" rid="R16">16</xref>). All these candidates affect the immune response known to oscillate during the day and their administration according to CR of SARS-CoV-2. Finally, the well documented CR disturbance in intensive care units (<xref ref-type="bibr" rid="R17">17</xref>) should be considered in the clinical and therapeutic management of patients with severe Covid-19.</p>
</sec>
<sec id="S4" sec-type="methods">
<title>Methods</title>
<sec id="S5">
<title>Cells and virus</title>
<p id="P8">SARS-CoV-2 strain MI6 was cultured in Vero E6 cells (American type culture collection ATCC<sup>®</sup> CRL-1586™) in Minimum Essential Media (Life Technologies, Carlsbad, CA, USA) supplemented with 4% fetal bovine serum (FBS), as previously described (<xref ref-type="bibr" rid="R18">18</xref>).</p>
<p id="P9">Human monocytes were isolated from peripheral blood mononuclear cells from healthy donors (convention <italic>n°7828</italic>, Etablissement Français du Sang, Marseille, France) following CD14 selection using MACS magnetic beads (Miltenyi Biotec, Bergisch, Germany) as previously described (<xref ref-type="bibr" rid="R19">19</xref>). Monocytes were cultured in Roswell Park Memorial Institute medium-1640 (Life Technologies) containing 10% of FBS, 100 U/mL penicillin and 50 μg/mL streptomycin (Life Technologies). Monocytes were infected with 50 μ1 virus suspension (0.1 multiplicity of infection (MOI)) during bathyphase (ZT6) and acrophase (ZT17) for 48 hours at 37°C in the presence of 5% CO<sub>2</sub>.</p>
</sec>
<sec id="S6">
<title>Circadian gene expression</title>
<p id="P10">Total RNA was extracted using the RNA Mini Kit (Qiagen) and a quantitative Real-Time PCR was performed according to the manufacturer’s instructions (MMLV Kit, Life Technologies and Smart SYBRGreen kit, Roche Applied Science). Circadian gene expression was investigated using specific primers targeting <italic>Bmall</italic> and <italic>Clock</italic> genes (<xref ref-type="bibr" rid="R8">8</xref>). Results were normalized using the housekeeping endogenous control <italic>actb</italic> gene (β-actin). The results are expressed according to the appropriate formula: gene expression = Log (2<sup>-ΔCt</sup>) relative expression, with Ct (Cycle threshold), ACt = Ct target gene - Ct β-actin. The Cosinor analysis based on an extrapolation from measurements of a few points over 24 hours was used to evaluate the CR of the clock genes <italic>Bmall</italic> and <italic>Clock</italic>.</p>
</sec>
<sec id="S7">
<title>Viral RNA extraction and PCR</title>
<p id="P11">Viral RNA was extracted from the infected cells using NucleoSpin<sup>®</sup> Viral RNA Isolation kit (Macherey-Nagel) and Covid-19 virus detection was performed using One-Step qRT-PCR Superscript™ III Platinum™ (Life Technologies) targeting the gene E, as previously described (<xref ref-type="bibr" rid="R20">20</xref>).</p>
</sec>
<sec id="S8">
<title>Immunofluorescence</title>
<p id="P12">Infected cells (5. 10<sup>5</sup> cells/well) were fixed and incubated with phalloidin-555 and 4’,6-diamidino-2-phenylindole (DAPI) to labelled F-actin and nucleus respectively. SARS-CoV-2 virus was labelled using first an anti-SARS-CoV-2 antibody (Spike protein, Thermo Fischer) and then a secondary anti-rabbit Alexa 647 (Thermo Fisher).</p>
<p id="P13">Pictures were acquired using confocal microscopy (LSM 8000 Airyscan confocal microscope, × 63, oil objective) and the phagocytosis index was calculated according to the following formula: percentage of phagocytosis ((average number of infected cells × 100)/total number of counted cells) × average number of particles or viruses/cells).</p>
</sec>
<sec id="S9">
<title>Immunoassays</title>
<p id="P14">Levels of interleukin (IL)-6, IL-1β and IL-10 were measured in cell supernatants using an enzyme-linked immunosorbent assay technique (R&amp;D systems). The sensitivity of the assays was (pg/ml) 15.4 for IL-6, 0.125 for IL,-1β and 3.9 for IL-10.</p>
</sec>
<sec id="S10">
<title>Statistical analysis</title>
<p id="P15">Statistical analyses were performed with GraphPad Prism (7.0, La Jolla, CA) and R studio v3.4.0. Continuous variables were expressed as medians ± interquartile, and comparisons between two groups were made using the Mann-Whitney non-parametric test for unmatched data and the Student t-test for matched data. Statistical significance was defined as <italic>P</italic>≤0.05.</p>
</sec>
</sec>
</body>
<back>
<ack id="S11">
<title>Funding Statement</title>
<p id="P16">Soraya Mezouar was first supported by the “Fondation pour la Recherche Médicale” postdoctoral fellowship (reference: SPF20151234951) and then by the “Fondation Méditerranée Infection”. This work was supported by the French Government under the “Investissements d’avenir” (investments for the future) program managed by the “Agence Nationale de la Recherche” (reference: 10-IAHU-03).</p>
</ack>
<fn-group>
<fn fn-type="conflict" id="FN3">
<p id="P17">
<bold>Disclosure Statement</bold>
</p>
<p id="P18">The authors declare no conflict of interest.</p>
</fn>
<fn fn-type="con" id="FN2">
<p id="P19">
<bold>Author contributions</bold>
</p>
<p id="P20">A.B.D and L.G performed experiments. A.B.D, B.C and S.M analyzed the data. A.B.D, M.L, S.M and J.L.M supervised the work. A.B.D, S.M and J.L.M wrote the manuscript. All authors reviewed and approved the submitted manuscript. All authors reviewed the draft of the manuscript and provided intellectual input.</p>
</fn>
</fn-group>
<ref-list>
<ref id="R1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ray</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Reddy</surname>
<given-names>AB</given-names>
</name>
</person-group>
<year>2020</year>
<article-title>COVID-19 management in light of the circadian clock</article-title>
<source>Nat Rev Mol Cell Biol</source>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41580-020-0275-3">https://doi.org/10.1038/s41580-020-0275-3</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meira e Cruz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Miyazawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gozal</surname>
<given-names>D</given-names>
</name>
</person-group>
<year>2020</year>
<article-title>Putative contributions of circadian clock and sleep in the context of SARS-CoV-2 infection</article-title>
<source>Eur Respir J</source>
<volume>55</volume>
<fpage>2001023</fpage>
</element-citation>
</ref>
<ref id="R3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tognini</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Thaiss</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Elinav</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sassone-Corsi</surname>
<given-names>P</given-names>
</name>
</person-group>
<year>2017</year>
<article-title>Circadian coordination of antimicrobial responses</article-title>
<source>Cell Host Microbe</source>
<volume>22</volume>
<fpage>185</fpage>
<lpage>192</lpage>
</element-citation>
</ref>
<ref id="R4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diallo</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Coiffard</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Leone</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mezouar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mege</surname>
<given-names>J-L</given-names>
</name>
</person-group>
<year>2020</year>
<article-title>For Whom the Clock Ticks: Clinical Chronobiology for Infectious Diseases</article-title>
<source>Front Immunol</source>
<volume>11</volume>
<fpage>1457</fpage>
</element-citation>
</ref>
<ref id="R5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Majumdar</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Dhar</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kondratov</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Barik</surname>
<given-names>S</given-names>
</name>
</person-group>
<year>2017</year>
<article-title>Circadian transcription factor BMAL1 regulates innate immunity against select RNA viruses</article-title>
<source>Innate Immun</source>
<volume>23</volume>
<fpage>147</fpage>
<lpage>154</lpage>
</element-citation>
</ref>
<ref id="R6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edgar</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Stangherlin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nagy</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Nicoll</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Efstathiou</surname>
<given-names>S</given-names>
</name>
<name>
<surname>O’Neill</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Reddy</surname>
<given-names>AB</given-names>
</name>
</person-group>
<year>2016</year>
<article-title>Cell autonomous regulation of herpes and influenza virus infection by the circadian clock</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>113</volume>
<fpage>10085</fpage>
<lpage>10090</lpage>
</element-citation>
</ref>
<ref id="R7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sengupta</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Devine</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Nayak</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Valenzuela</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>López</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>FitzGerald</surname>
<given-names>GA</given-names>
</name>
</person-group>
<year>2019</year>
<article-title>Circadian control of lung inflammation in influenza infection</article-title>
<source>Nat Commun</source>
<volume>10</volume>
<fpage>4107</fpage>
</element-citation>
</ref>
<ref id="R8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coiffard</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Diallo</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Culver</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mezouar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hammad</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Vigne</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Nicolino-Brunet</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dignat-George</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Baumstarck</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Boucekine</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Leone</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<year>2019</year>
<article-title>Circadian rhythm disruption and sepsis in severe trauma patients</article-title>
<source>Shock Augusta Ga</source>
<volume>52</volume>
<fpage>29</fpage>
<lpage>36</lpage>
</element-citation>
</ref>
<ref id="R9">
<label>9</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Fehr</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Perlman</surname>
<given-names>S</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>Coronaviruses: An Overview of Their Replication and Pathogenesis</article-title>
<fpage>1</fpage>
<lpage>23</lpage>
<person-group person-group-type="editor">
<name>
<surname>Maier</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Bickerton</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Britton</surname>
<given-names>P</given-names>
</name>
</person-group>
<source>Coronaviruses</source>
<publisher-name>Springer New York</publisher-name>
<publisher-loc>New York, NY</publisher-loc>
</element-citation>
</ref>
<ref id="R10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhuang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Magri</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rambhatla</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Donald</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Lopez-Clavijo</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Rudge</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pinnick</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>WH</given-names>
</name>
<etal/>
</person-group>
<year>2019</year>
<article-title>The circadian clock components BMAL1 and REVERBa regulate flavivirus replication</article-title>
<source>Nat Commun</source>
<volume>10</volume>
<fpage>377</fpage>
</element-citation>
</ref>
<ref id="R11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gordon</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Bouhaddou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Obernier</surname>
<given-names>K</given-names>
</name>
<name>
<surname>White</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>O’Meara</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Rezelj</surname>
<given-names>VV</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>JZ</given-names>
</name>
<name>
<surname>Swaney</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Tummino</surname>
<given-names>TA</given-names>
</name>
<etal/>
</person-group>
<year>2020</year>
<article-title>A SARS-CoV-2 protein interaction map reveals targets for drug repurposing</article-title>
<source>Nature</source>
<volume>583</volume>
<fpage>459</fpage>
<lpage>468</lpage>
</element-citation>
</ref>
<ref id="R12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Merad</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>JC</given-names>
</name>
</person-group>
<year>2020</year>
<article-title>Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages</article-title>
<source>Nat Rev Immunol</source>
<volume>20</volume>
<fpage>355</fpage>
<lpage>362</lpage>
</element-citation>
</ref>
<ref id="R13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L</given-names>
</name>
</person-group>
<year>2019</year>
<article-title>New Insights Into the Circadian Rhythm and Its Related Diseases</article-title>
<source>Front Physiol</source>
<volume>10</volume>
<fpage>682</fpage>
</element-citation>
</ref>
<ref id="R14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
</person-group>
<year>2020</year>
<article-title>COVID-19: immunopathogenesis and Immunotherapeutics</article-title>
<source>Signal Transduct Target Ther</source>
<volume>5</volume>
<fpage>128</fpage>
</element-citation>
</ref>
<ref id="R15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruben</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>FitzGerald</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Hogenesch</surname>
<given-names>JB</given-names>
</name>
</person-group>
<year>2019</year>
<article-title>Dosing time matters</article-title>
<source>Science</source>
<volume>365</volume>
<fpage>547</fpage>
<lpage>549</lpage>
</element-citation>
</ref>
<ref id="R16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saghazadeh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rezaei</surname>
<given-names>N</given-names>
</name>
</person-group>
<year>2020</year>
<article-title>Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids</article-title>
<source>Int Immunopharmacol</source>
<volume>84</volume>
<fpage>106560</fpage>
</element-citation>
</ref>
<ref id="R17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKenna</surname>
<given-names>H</given-names>
</name>
<name>
<surname>van der Horst</surname>
<given-names>GTJ</given-names>
</name>
<name>
<surname>Reiss</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>D</given-names>
</name>
</person-group>
<year>2018</year>
<article-title>Clinical chronobiology: a timely consideration in critical care medicine</article-title>
<source>Crit Care</source>
<volume>22</volume>
<fpage>124</fpage>
</element-citation>
</ref>
<ref id="R18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andreani</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Le Bideau</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Duflot</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Jardot</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rolland</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Boxberger</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wurtz</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Rolain</surname>
<given-names>J-M</given-names>
</name>
<name>
<surname>Colson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>La Scola</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Raoult</surname>
<given-names>D</given-names>
</name>
</person-group>
<year>2020</year>
<article-title>In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect</article-title>
<source>Microb Pathog</source>
<volume>145</volume>
<fpage>104228</fpage>
</element-citation>
</ref>
<ref id="R19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ben Azzouz</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Boumaza</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mezouar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bardou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Carlini</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Picard</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Raoult</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mège</surname>
<given-names>J-L</given-names>
</name>
<name>
<surname>Desnues</surname>
<given-names>B</given-names>
</name>
</person-group>
<year>2018</year>
<article-title>Tropheryma whipplei increases expression of human leukocyte antigen-G on monocytes to reduce tumor necrosis factor and promote bacterial replication</article-title>
<source>Gastroenterology</source>
<volume>155</volume>
<fpage>1553</fpage>
<lpage>1563</lpage>
</element-citation>
</ref>
<ref id="R20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amrane</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tissot-Dupont</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Doudier</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Eldin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hocquart</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mailhe</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dudouet</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ormières</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ailhaud</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Parola</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lagier</surname>
<given-names>J-C</given-names>
</name>
<etal/>
</person-group>
<year>2020</year>
<article-title>Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot</article-title>
<source>Travel Med Infect Dis</source>
<fpage>101632</fpage>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<title>SARS-CoV-2 infection is link to circadian rhythm</title>
<p>
<bold>(A)</bold> Circadian rhythm of <italic>BMAL1</italic> and <italic>CLOCK</italic> genes in monocyte using Cosinor model. <bold>(B)</bold> Virus load at ZT6 and ZT17 time. <bold>(C)</bold> Phagocytosis index and representative pictures of monocytes (F-actin in green and nucleus in blue) infected by SARS-CoV-2 virus (red). <bold>(D)</bold> Level of IL-6, Π.-1β and IL-10 of unstimulated (red) and infected cells at ZT6 and ZT17.</p>
</caption>
<graphic xlink:href="EMS94986-f001"/>
</fig>
</floats-group>
</article>
